Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin® as First-line Therapy for Liver Metastases Considered as Potentially Resectable

NCT01343901 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01343901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study of Patients With Metastatic Colorectal Cancer Treated With Avastin® as First-line Therapy for Liver Metastases Considered as Potentially Resectable
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2015
Enrollment
210 (actual)
Sites
126

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer